TrademarkDir
AMOCELL
LIVE

Serial Number

79253893

Owner

Otsuka Pharmaceutical Factory, Inc.

Attorney

Jeffrey D. Larson

Filing Date

Dec 11, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AMOCELL Trademark

Serial Number: 79253893 • Registration: 5969770

AMOCELL is a trademark filed by Otsuka Pharmaceutical Factory, Inc. on December 11, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Otsuka Pharmaceutical Factory, Inc. (3 trademarks)

115 Kuguhara, Tateiwa,

Entity Type: 03

Trademark Details

Filing Date

December 11, 2018

Registration Date

January 28, 2020

Published for Opposition

November 12, 2019

Cancellation Date

August 14, 2026

Goods & Services

Solutions for cell preservation for medical and veterinary purposes; preparations for medical and veterinary purposes namely, solutions for cell preservation for research relating to medical and veterinary treatment; reagents for medical purposes; medical diagnostic reagents; veterinary diagnostic reagents; biochemical preparations for medical or veterinary purposes

Chemicals for use in the biochemical and chemical industry; solutions for cell preservation other than for medical, veterinary or medical research purposes; biochemical preparations for scientific purposes; biological preparation for use in cell cultures other than for medical or veterinary use

Filing History

CANCELLED SECTION 71
Aug 14, 2026 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Mar 5, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 28, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 29, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 9, 2020 FICS
FINAL DISPOSITION PROCESSED
May 9, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Nov 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 23, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2019 NONP
ASSIGNED TO LIE
Oct 9, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 26, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 4, 2019 RFCS
REFUSAL PROCESSED BY MPU
Apr 4, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 30, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 11, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2019 REPR

Related Trademarks

More from this Owner

CELLSTOR

CELLSTOR

DIATRANZ

DIATRANZ

DIATRANZ

DIATRANZ

OTSUKA CLINICAL NUTRITION AMERICA

OTSUKA CLINICAL NUTRITION AMERICA

BFLUID

BFLUID

BFLUID

BFLUID